Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway

…, AJ Aguirre, SR Viswanathan, S Chattopadhyay… - Nature, 2017 - nature.com
Plasticity of the cell state has been proposed to drive resistance to multiple classes of cancer
therapies, thereby limiting their effectiveness 1 , 2 , 3 , 4 . A high-mesenchymal cell state …

[HTML][HTML] Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption

A Qiu, M Jansen, A Sakaris, SH Min, S Chattopadhyay… - Cell, 2006 - cell.com
Folates are essential nutrients that are required for one-carbon biosynthetic and epigenetic
processes. While folates are absorbed in the acidic milieu of the upper small intestine, the …

Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications

S Chattopadhyay, RG Moran, ID Goldman - Molecular cancer therapeutics, 2007 - AACR
Pemetrexed is a new-generation antifolate, approved for the treatment of mesothelioma and
non–small cell lung cancer, currently being evaluated for the treatment of a variety of other …

[PDF][PDF] Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein

…, AT Alistar, ED Whitman, SA Bertino, S Chattopadhyay… - Immunity, 2020 - cell.com
Developing effective strategies to prevent or treat coronavirus disease 2019 (COVID-19)
requires understanding the natural immune response to severe acute respiratory syndrome …

Niche-based screening identifies small-molecule inhibitors of leukemia stem cells

…, T Kindler, Z Tothova, S Chattopadhyay… - Nature chemical …, 2013 - nature.com
Efforts to develop more effective therapies for acute leukemia may benefit from high-throughput
screening systems that reflect the complex physiology of the disease, including leukemia …

An isochemogenic set of inhibitors to define the therapeutic potential of histone deacetylases in β-cell protection

…, P McCarren, YL Zhang, S Chattopadhyay… - ACS chemical …, 2016 - ACS Publications
Modulation of histone deacetylase (HDAC) activity has been implicated as a potential
therapeutic strategy for multiple diseases. However, it has been difficult to dissect the role of …

The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of …

ID Goldman, S Chattopadhyay, R Zhao… - Current opinion in …, 2010 - europepmc.org
More than 50 years after the introduction of the dihydrofolate reductase inhibitor, methotrexate,
new antifolates have emerged and have been incorporated into the chemotherapeutic …

HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of β-catenin in human iPSC-derived neuronal cells

…, JH Huang, SS Berkovitch, S Chattopadhyay… - ACS chemical …, 2015 - ACS Publications
We examined the effects of isoform-specific histone deacetylase (HDAC) inhibitors on β-catenin
posttranslational modifications in neural progenitor cells (NPCs) derived from human …

MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM

…, M Welin, S Chattopadhyay… - Proceedings of the …, 2019 - National Acad Sciences
Activation of the Met receptor tyrosine kinase, either by its ligand, hepatocyte growth factor (HGF),
or via ligand-independent mechanisms, such as MET amplification or receptor …

Selective preservation of pemetrexed pharmacological activity in HeLa cells lacking the reduced folate carrier: association with the presence of a secondary transport …

R Zhao, M Hanscom, S Chattopadhyay, ID Goldman - Cancer research, 2004 - AACR
A methotrexate (MTX)-resistant HeLa subline (R5), developed in this laboratory, with
impaired transport due to a genomic deletion of the reduced folate carrier (RFC) was only 2-fold …